Molecular Pathology & Genomics

New approach for ovarian cancer treatment?

Immune checkpoint inhibitors are a type of cancer treatment that help the immune system’s T cells recognise and attack tumours. But these immunotherapy drugs aren’t effective against all cancers.

Potential vaccine and treatment for alzheimer’s

A promising new approach to potentially treat Alzheimer’s disease – and also vaccinate against it – has been developed by a team of UK and German scientists.

Genomic medicine: breaking new ground

Cancer Genomics Project Manager Deborah Lakeland describes the cultural change sweeping across healthcare provision in the UK and its importance in clinical laboratories.

Shining a light ...on lighthouse laboratories

We look back over the history of the lighthouse labs and whether better quality control and tighter regulation are needed.

An immersive experience: cancer exhibition at the Crick

The Francis Crick Institute has opened Outwitting Cancer – Making Sense of Nature’s Enigma, an immersive exhibition and the first to take place within a working science laboratory, home to cancer scientists from across the world. Here, Exhibitions Manager Hana Dethlefsen talks through the launch.

Tech news: October

This month's top tech news stories

Under the microscope: chronic allograft dysfunction

What is chronic allograft dysfunction (CLAD)?

A range of pathologies that cause a transplanted lung to not achieve or maintain normal function. CLAD manifests as airflow restriction or obstruction.

Diagnose crohn’s with an engineered organism

Researchers have engineered a bacterium with the necessary capabilities for diagnosing a human disease.

Genomic medicine: Coming to the clinic near you?

Dr Rameen Shakur takes a look at how biomedical science and genomics are playing a part in real-world clinical cardiology.

Unintended consequences

Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.

The evolution of quality assessment

In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.

Top